Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03325556
Brief Title: Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

First Submitted : October 18, 2017
First Submitted that Met QC Criteria : October 25, 2017
First Posted : October 30, 2017

Results First Submitted : April 30, 2021
Results First Submitted that Met QC Criteria : May 27, 2021
Results First Posted : June 21, 2021

Certification/Extension First Submitted : April 15, 2020
Certification/Extension First Submitted that Met QC Criteria : May 27, 2021
Certification/Extension First Posted : June 21, 2021

Last Update Submitted that Met QC Criteria : May 27, 2021
Last Update Posted : June 21, 2021